Biotech - Press Releases

Date	Title	Company
23-Dec-2020	Rakuten Medical Enrolls First Patient in the U.S. Clinical Trial for its Lead Product, ASP-1929 in Combination with Anti-PD1 Therapy, for Head and Neck Cancer or Cutaneous Squamous Cell Carcinoma	Rakuten Medical, Inc.
23-Dec-2020	BioInvent receives $3 million payment related to selection of antibodies under collaboration with Pfizer Inc.	BioInvent
22-Dec-2020	Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol "PHAR"	Pharming Group N.V.
22-Dec-2020	FDA Warns Companies Illegally Selling CBD Products	U.S. Food and Drug Administration
22-Dec-2020	VFMCRP and ChemoCentryx provide topline results from ACCOLADE trial of avacopan in C3 glomerulopathy including improved estimated glomerular filtration rate (eGFR)	Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
22-Dec-2020	Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study	Bone Therapeutics
22-Dec-2020	Chi-Med to Present at the 39th Annual JP Morgan Healthcare Conference	Chi-Med
22-Dec-2020	Update on the recently acquired NTCD-M3 biotherapeutic clinical programme for prevention of recurrence of C. difficile infections	Destiny Pharma plc
22-Dec-2020	GLOBAL TEAM OF SCIENTISTS UNITE TO ASSESS ROLE OF T CELLS IN THE BATTLE AGAINST COVID-19 AND EVALUATE STEPS IN MANAGING AND PROTECTING AGAINST FUTURE INFECTIOUS DISEASE	Global T cell Expert Consortium
22-Dec-2020	Polyphor receives approval to start first-in-human clinical trial of inhaled antibiotic murepavadin	Polyphor
22-Dec-2020	Bone Therapeutics finalise le recrutement et le traitement des patients dans son étude pivot de Phase III évaluant le JTA-004 dans l’arthrose du genou	Bone Therapeutics
22-Dec-2020	VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)	Vifor Pharma Group
22-Dec-2020	UKCPA Meets Demand For Critical Care Training With New Online	The UK Clinical Pharmacy Association (UKCPA)
22-Dec-2020	Transgene and BioInvent receive CTA approval for Phase 1/2a trial of oncolytic virus BT-001 in solid tumors	Transgene
22-Dec-2020	Janssen Announces European Commission Authorisation of the First Complete Long-Acting Injectable HIV Treatment in Europe	Janssen Pharmaceutical Companies of Johnson & Johnson
22-Dec-2020	GLOBAL HEALTHCARE SECTOR INVESTS OVER £1.3 MILLION TO BOOST INTERNAL COMMUNICATIONS	St George’s University Hospitals NHS Foundation Trust
22-Dec-2020	Exclusive Interview with Mark DePristo, BigHat BioScience speaker at AI in Drug Discovery 2021	SMi Group
22-Dec-2020	Amgen Submits Sotorasib Marketing Authorization Application To The European Medicines Agency	Amgen
22-Dec-2020	Mitsubishi Tanabe Pharma America Announces Initiation of Open-Label Extension Study of Oral Edaravone in ALS	Mitsubishi Tanabe Pharma America, Inc.
22-Dec-2020	Amgen Submits Sotorasib Marketing Authorization Application To The European Medicines Agency	Amgen